NMN for Androgenic Hair Thinning: What the Evidence Actually Shows
What is Androgenic Hair Thinning?
Androgenic hair thinning is the progressive loss of scalp hair driven by genetic sensitivity to dihydrotestosterone (DHT). It affects both men and women with different patterns.
NMN relevance: the published evidence
There is no human evidence that NMN treats androgenic alopecia. The hair-loss pathway is hormonal, not primarily NAD-dependent. Minoxidil, finasteride (men), spironolactone (women) and low-level laser therapy have established evidence.
Questions to ask before supplementing
No dose validated for hair endpoints.
Contraindications and red flags
Consult a dermatologist for evaluation; NMN is not a hair-loss treatment.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have androgenic hair thinning, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Skin Photoaging - Skin photoaging is the cumulative damage from UV exposure, producing wrinkles, pigmentation, loss of...
- Biological Aging - Biological aging refers to the gradual decline in cellular and organ function that accompanies chron...
- Menopause - Menopause is confirmed after 12 consecutive months without menstruation, typically around age 50. It...
- Male Fertility Decline and Andropause - Male fertility declines more slowly than female, but sperm quality drops with age. Andropause refers...